This week I was mostly in the lab. I spent time analyzing bulk RNA datasets and selecting samples/datasets suitable for downstream analyses from the ICSBCS biobank. I also compiled the information available on WGS datasets of these samples. The next steps involve selecting samples and datasets best suitable for cross comparison of tumor information from the ICSBCS biobank based on the information from WGS, RNAseq and metadata.
I also attended the MDC tumor board earlier this week. This week's cases ranged from new patients to patients who already had surgeries and were undergoing post operative care. Discussions mostly involved treatment plans coming from surgical oncologists and medical oncologists. Later in the week I attended a presentation by a sub-intern working with Dr. Newman on the key features of breast cancer. We discussed the anatomy, current best practices for diagnosis including breast self exam, best practices in breast cancer care and factors involved in decision making for breast cancer surgery. I also attended a didactic session conducted by Dr. Newman on Inflammatory Breast Cancer (IBC). She discussed the background, diagnosis methods and current treatments available for IBC. It was interesting to learn despite advances in breast cancer care so little is known about IBC.
No comments:
Post a Comment